Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon.
暂无分享,去创建一个
[1] J. Galton,et al. ANTIBODIES TO LYMPHOBLASTOID INTERFERON , 1989, The Lancet.
[2] B. Leventhal,et al. Detection and incidence of neutralizing antibodies to interferon-alpha-n1. , 1989, Journal of interferon research.
[3] A. Yonkers,et al. Randomized Surgical Adjuvant Trial of Interferon Alfa-n1 in Recurrent Papillomatosis , 1988 .
[4] D. K. Kelsey,et al. Minimal antigenicity of intron A in human recipients demonstrated by three analytical methods. , 1988, Journal of biological response modifiers.
[5] D. Longo,et al. Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies. , 1988, The New England journal of medicine.
[6] A. Yonkers,et al. Interferon alfa‐n1 (wellferon)® in juvenile onset recurrent respiratory papillomatosis: Results of a randomized study in twelve collaborative institutions , 1988, The Laryngoscope.
[7] H. Deicher,et al. CLINICAL SIGNIFICANCE OF ANTI-IFN-α ANTIBODY TITRES DURING INTERFERON THERAPY , 1987, The Lancet.
[8] J. Gutterman,et al. Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa‐2a by intramuscular injection , 1987, Cancer.
[9] P. Broek,et al. Results of treatment with alpha‐interferon in adult‐onset laryngeal papillomatosis , 1986 .
[10] L. Itri,et al. Safety and tolerance of recombinant interferon alfa‐2a (roferon®‐A) in Cancer Patients , 1986, Cancer.
[11] R. Spiegel,et al. Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A). , 1986, The American journal of medicine.
[12] J. Quesada,et al. Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] H. Zenner,et al. Recombinant interferon-alpha-2C in laryngeal papillomatosis: preliminary results of a prospective multicentre trial. , 1985, Oncology.
[14] H. Strander,et al. Interferon Therapy in Juvenile Laryngeal Papillomatosis , 1984, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[15] A. Bomholt. Interferon therapy for laryngeal papillomatosis in adults. , 1983, Archives of otolaryngology.
[16] J. Quesada,et al. Clinical study of recombinant DNA-produced leukocyte interferon (clone A) in a intermittent schedule in cancer patients. , 1983, Journal of the National Cancer Institute.
[17] J. Quesada,et al. ANTIBODIES TO HUMAN LEUCOCYTE INTERFERONS IN CANCER PATIENTS , 1983, The Lancet.
[18] B. Mccabe,et al. Interferon and Laryngeal Papillomatosis , 1983, The Annals of otology, rhinology, and laryngology.
[19] J. Gutterman,et al. Leukocyte Interferon in Patients with Juvenile Laryngeal Papillomatosis , 1982, The Annals of otology, rhinology, and laryngology.
[20] C. Cremers,et al. Treatment of Juvenile Laryngeal Papillomatosis with Two Types of Interferon , 1982 .
[21] T. Merigan,et al. Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. , 1982, Annals of internal medicine.
[22] K. Cantell,et al. Interferon therapy in juvenile laryngeal papillomatosis. , 1981, Archives of otolaryngology.